The Glenway Health Plan's pharmacy and therapeutics (P&T) committee conducted pharmacoeconomic research to measure both the clinical outcomes and costs of two new cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research that Glenway conducted in this situation was most likely
Catalina
9 months agoSina
9 months agoBeckie
10 months agoJulio
10 months agoSol
10 months agoIzetta
10 months agoLettie
10 months agoAllene
10 months ago